Citation

Akram G. Pharmacy in Practice 2007; 17(3): 115-118.

Copyright

(Copyright © 2007)

DOI

unavailable

PMID

unavailable

Abstract

[Abstract unavailable]

Language: en

Keywords

human; suicide; insomnia; suicidal ideation; stroke; randomized controlled trial; suicide attempt; clinical trial; review; anorexia; weight reduction; drug metabolism; tachycardia; unclassified drug; controlled clinical trial; headache; practice guideline; gastrointestinal symptom; heart infarction; placebo; seizure; drug cost; drug withdrawal; drug misuse; amphetamine derivative; cardiovascular disease; hypertension; side effect; attention deficit disorder; drug surveillance program; methylphenidate; QT prolongation; liver toxicity; drug half life; drug elimination; liver dysfunction; nervousness; dexamphetamine; atomoxetine; jaundice; bilirubin blood level; drug release; tablet formulation; serotonin noradrenalin reuptake inhibitor; liver function test; equasym; sustained drug release